Risedronate is the latest of the bisphosphonates to be used for the management of resorptive bone disease. Clinical improvements, assessed by the incidence of fracture and changes in bone mineral ...

Risedronate is a bisphosphonate which also includes the drugs alendronate prescribed for the treatment of Paget's disease of bone (a disease in which the formation of bone is abnormal) and in ...

report the first-year outcomes of a 2-year, multicenter, parallel group, randomized, controlled trial to evaluate the efficacy and safety of twice-monthly versus daily oral risedronate for ...

Risedronate is an orally administered drug which should be taken once daily at least 30 minutes prior to food or drink (other than water). It is recommended that the patient take the drug with a ...